Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of personalized medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Mar 31, 2020

Tim Moran, CEO, Motus GI talks about their focus on endoscopy solutions that improve clinical outcomes for patients facing a critical colonoscopy while in the hospital.  The Pure-Vu system developed by Motus GI is a disposable sleeve that fits on the top of their reusable scope to allow irrigation and suction...


Mar 31, 2020

Tim Moran, CEO, Motus GI talks about their focus on endoscopy solutions that improve clinical outcomes for patients facing a critical colonoscopy while in the hospital.  The Pure-Vu system developed by Motus GI is a disposable sleeve that fits on the top of their reusable scope to allow irrigation and suction...


Mar 30, 2020

Greg Merril, CEO, Adaptive Phage Therapeutics describes useful viruses that host on and kill bacteria acting as nature's natural antibiotic.  Phage therapy actually predates antibiotics but recent research has enabled scientist to better identify which phage will have the desired impact on specific bacteria.  Greg talks...


Mar 30, 2020

Greg Merril, CEO, Adaptive Phage Therapeutics describes useful viruses that host on and kill bacteria acting as nature's natural antibiotic.  Phage therapy actually predates antibiotics but recent research has enabled scientist to better identify which phage will have the desired impact on specific bacteria.  Greg talks...


Mar 24, 2020

Dr. Hartmut Ehrlich, CEO, Abivax  gives an update of the French biotech's phase-2b clinical trial drug candidate ABX464 which has shown impressive results.  Dr. Ehrlich discusses how this revolutionary small molecule for oral administration has shown strong anti-inflammatory effects to solve the unmet needs of patients...